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Methods: We evaluated two ELISA methods to improve
the sensitivity and accuracy. Biotin-streptavidin technology
was selected to enhance the ELISA limit of detection due to
the high binding affinity of biotin-streptavidin. GNP-con-
jugated biomolecules were selected to improve detection by
ELISA. To evaluate these two methods, the early secreted
antigenic target-6 (ESAT-6) fromMycobacterium tubercu-
losis and the anti-ESAT-6 antibody were used.
Results: The detection limit of ESAT-6 was the same
with and without GNP due to the saturation of biotin
and streptavidin binding. However, higher absorbance
was noticed using GNP only.
Conclusion: The proposed modified ELISA can be used
to screen different types of common diseases. Addition-
ally, this study showed how several new techniques can
improve the detection and accuracy of ELISA.
Keywords: Biotin; ELISA; GNP; Streptavidin; Tuberculosis
 2016 The Authors.
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Enzyme Linked Immunosorbent assay (ELISA) is widely
used to detect antigens relating to disease using anhis is an open access article under the CC BY-NC-ND license
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sive, involves safe materials and gives accurate results.1,2
Many disease-causing agents are detected by ELISA,
including early secreted antigenic target-6 (ESAT-6),3
glucose levels,4 duck tembusu virus,5 histoplasmosis,6 and
human fetuin A.7 Because ELISA is widely used to screen
for disease, improving ELISA techniques is important to
enhance the ability to detect diseases. ELISA detection
limits depend on factors such as capture antibody
immobilization, pH, temperature, ligand binding affinity
and analyte. Importantly, surface functionalization and
biomolecular interactions can help to improve the limit of
detection. In the surface functionalization process, the
capture and detection antibodies are important to consider
because less capture antibody leads a reduction in
sensitivity. Many researchers have attempted to improve
ELISA detection by immobilizing higher amounts of
antibodies or antigens on an ELISA plate. Antibodies and
antigens can bind ELISA plates through electrostatic,
chemical or physical interactions. Vashit et al.8 improved
ELISA detection by immobilizing more antibody on an
ELISA plate in just one step.
On the other hand, biomolecular affinity also plays an
important role in improving the detection of ELISA. In this
case, the maximum binding of an analyte and ligand can be
improved, increasing the limit of detection. Biotin-
streptavidin technology has been effectively used to
improve ELISA detection due to the strong affinity between
biotin and streptavidin because it has a dissociation con-
stant (Kd) in the femtomolar range. Biotinylated probes are
generally used to tag antibodies, deoxyribonucleic acid
(DNA) or peptides for subsequent detection using enzyme-
conjugated streptavidin. Because biotin and streptavidin
interact strongly, more analyte molecules can be captured
on an ELISA plate can be captured. On the other hand,
nanomaterial application of the biosensor was used to
improve detection and stabilize analyte molecules. Among
other materials, gold nanoparticle (GNP) is a very attractive
material because it easy to use and is stable. It was
demonstrated that the use of various sensors, such as sur-
face plasmon resonance (SPR), waveguide mode sensor,
SPR-based Biacore and Raman spectroscopy, GNP
improved the limit of detection.9e13 Making use of the good
characteristics of GNP, here, we used GNP-conjugated
biomolecules to improve ELISA. A GNP conjugated pri-
mary antibody and secondary antibody as well as
streptavidin-HRP (Streptavidin-Horseradish Peroxidase)
were used to improve detection of the analyte. The goal is to
use antibody conjugation with GNP to increase antibody
capture, leading to improved analyte binding, induced high
sensitive detection. GNP conjugated biomolecules are also
very stable, even in crude samples, such as serum. In this
work, we compared and attempted to improve the detection
of biomolecules with ELISA-assisted biotin-streptavidin
technology and GNP.
The model protein that was chosen for detection in
ELISA is ESAT-6 from Mycobacterium tuberculosis.
Tuberculosis (TB) is a life-threatening disease that damages
lungs in humans.13,14 TB spreads very fast via air-borne
droplets, and the infection is difficult to control. Different
methods have been developed to detect TB, such as thetuberculin skin test, microscopic analyses or blood tests.15e17
When TB enters the bloodstream, it is difficult to detect in its
earliest stages. Therefore, it is necessary to develop a novel
method to detect TB during the earlier stages in blood-
borne infection to avoid spreading contagion and to imple-
ment cures quickly. The method used in this study is useful
for detecting different types of diseases with the use of an
appropriate antibody by ELISA.
Materials and Methods
Reagents and biomolecules
ELISA plates were purchased from Becton Dickinson
(France). ESAT-6 antibody and protein were purchased
from Sino Biological, Inc. (China). ELISA 5X coating buffer
purchased was from Biolegend. Anti-mouse ESAT-6 anti-
body was obtained from Santa Cruz Biotechnology (USA),
anti-mouse-IgG-HRP (anti-mouse Immunoglobulin G-
HRP) was obtained from Thermo-Scientific (USA), bovine
serum albumin (BSA) was obtained from Promega (USA),
biotinylated anti-mouse-IgG was obtained from Invitrogen
(USA), streptavidin-HRP was obtained from Thermo-
Scientific (Japan), and GNPs (10 and 80 nm) were obtained
from SigmaeAldrich. The HRP substrate was obtained from
Promega (USA), and the ELISA reader was obtained fromR
& M Chemicals (U.K.).
Preparation of GNP-biomolecule complexes
GNP-conjugated biomolecules were prepared as follows.
Precisely 1 mL [one optical density, (1 OD)] of a GNP (sizes
10 or 80 nm) solution was added to 100 ml of mouse ESAT-6
antibody, anti-mouse-IgG-HRP, biotinylated anti-mouse-
IgG antibody or streptavidin-HRP at a 100 mg/mL concen-
tration, and then, the mixture was stirred for 30 min at room
temperature (RT). Excess antibody was removed by centri-
fugation at 15,000 g for 15 min at 4 C. Uncovered areas on
GNP molecules were blocked with 2% BSA, and excess BSA
was removed by centrifugation. Finally, GNP-conjugated
antibodies were suspended in 1 mL of phosphate-buffered
saline (PBS) and stored at 4 C for further use.
Determination of GNP-conjugate stability by colourimetric
assay
To determine the stability of the GNP conjugates, we used
a colourimetric assay. Different concentrations of sodium
chloride (NaCl) were used to determine the GNP stability.
NaCl concentrations of 30, 60, 120, 250, 400, and 800 mM
were mixed with GNPs, and their stability was checked based
on well aggregation. Once the NaCl concentration was
determined (800 mM), it was added to the 1:500 dilution of
ESAT-6 antibody-GNP, anti-mouse-IgG-HRP-GNP, bio-
tinylated anti-mouse-IgG-GNP, streptavidin-HRP-GNP,
conjugated GNPs, or the control (i.e., GNPs without ESAT-
6 antibody). After 10 min, photographs were taken, and the
colourimetric results were obtained using a nanophotometer.
A wavelength scan was performed from 400 to 700 nm, and
the data were graphed using Excel.
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To detect ESAT-6 by using biotin-streptavidin technol-
ogy, ELISA plates were first coated with ESAT-6 (0e
500 nM, diluted in coating buffer). Next, the wells were
blocked with 3% BSA before addition of the ESAT-6 anti-
body (1:1000). Biotinylated anti-mouse-IgG (1:1000) was
added to bind the ESAT-6 antibody, and streptavidin-HRP
(1:10,000) was added and resolved using the HRP-substrate
to detect the presence of ESAT-6. Between each step, the
wells were washed five times with washing buffer. All ELI-
SAs were carried out at room temperature (RT). The optical
density (OD) of the substrate was measured using a plate
reader, and photographs were taken (using 3 optical zoom)
15 min after the substrate was added.
Comparisons of biotin-streptavidin technologies with or
without GNP
For comparison with biotin-streptavidin technologies and
to determine the effect of GNP, one of the following three
different methods was evaluated. For the first method, ESAT
antibody-GNP was used instead of the ESAT-6 antibody.
The second method used ESAT-6 antibody-GNP and
biotinylated-anti-mouse-IgG-GNP instead of the ESAT-6
antibody and biotinylated anti-mouse-IgG. The third
method used biotinylated anti-mouse-IgG, streptavidin-
HRP, ESAT-6 antibody-GNP, biotinylated anti-mouse-
IgG-GNP, and streptavidin-HRP-GNP instead of the
ESAT-6 antibody. These three methods were compared to
conventional ELISA detection of ESAT at 250 nM. Ten
nanometre (10 nm)-sized GNPs were used for all experi-
ments. The remaining biomolecular concentrations and pa-
rameters were the same as those of conventional ELISA.Figure 1: Schematic representation of ESAT-6 detection by ELISA m
ELISA. (a) Biotin-streptavidin based ELISA, (b) ELISA with ESAT-6
tinylated anti-mouse-IgG-GNP, (d) ELISA with ESAT-6 antibody-GNLimit of detection for ESAT-6
To determine the limit of detection of the ESAT-6 pro-
tein, we titrated from 8 nM to 250 nM. The detection limit
was also compared between biotin-streptavidin technology
and GNP technology. The formula used to calculate the limit
of detection was: average Optical Density (Blank) e Stan-
dard Deviation (Blank).GNP Size based improvement in ESAT-6 detection
In the previous experiments, we used 10 nm GNP-
conjugated biomolecules for ESAT-6 detection. To
improve ELISA, we tested GNP sizes of 80 nm and 10 nm.
Both 10 and 80 nm GNP-conjugated biomolecules were able
to detect 250 nm ESAT-6. Therefore, 80 nm GNP-
conjugated biomolecules were subsequently used to check
the limits of detection of ESAT-6. We next titrated the
ESAT-6 concentrations to determine the detection limits
under these GNP conditions and compared them to con-
ventional ELISA. The remaining biomolecular concentra-
tions and parameters were the same as those used for
conventional ELISA.Results
In this study, we conjugated GNPs with biomolecules to
improve the detection of ESAT-6 in ELISA and compared
these results from those determined using biotin-streptavidin
technology. Figure 1a is the schematic representation of a
biotin-streptavidin based ELISA. Three different combina-
tions of GNP-conjugated biomolecules were compared un-
der these conditions (Figure 1bed).ethod assisted by biotin-streptavidin technology and GNP-assisted
antibody-GNP, (c) ELISA with ESAT-6 antibody-GNP and bio-
P, biotinylated anti-mouse-IgG-GNP, and streptavidin-HRP GNP.
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ESAT-6 protein was detected by biotin-streptavidin
ELISA and compared with GNP-based ELISA. In these
ELISA methods the final interactions were monitored by
streptavidin-HRP. In this experiment, the effect of the biotin-
streptavidin interaction was assessed for ELISA without
GNPs and for the assayswith 10 nmsizedGNPs conjugated to
the ESAT-6 antibody, biotinylated anti-mouse-IgG, or
streptavidin-IgG-HRP (Figure 1). First, we confirmed the
stability of the prepared GNPs (10 and 80 nm). The stability
of the prepared ESAT-6 antibody-GNP, biotinylated anti-
mouse-IgG-GNP, and streptavidin-IgG-GNP all exhibitedFigure 2: Stability assay of prepared GNP-conjugated biomolecules in t
the appropriate protein and 800 mM NaCl. The spectrum was read a
conjugated molecules showed excellent stability with a peak at w5
showed aggregation at w630 nm and exhibited aggregation with a pu
Figure 3: Comparison between the conventional and GNP mediated
conventional method and compared with three different methods wi
showed high sensitivity compared with the other methods.excellent colourimetric stability with 800 mM NaCl. GNP-
conjugated molecules remained red, whereas GNPs lacking
molecules turned from red to purple due to aggregation.GNP-
conjugated biomolecules had a maximum absorption of
approximately 520 nm with dispersion, whereas when GNP
aggregated, the absorbance peak appeared at a wavelength of
approximately 630 nm (Figure 2).
Next, we assessed the ability of the three different
methods for their ability to detect 250 nM ESAT-6.
Compared to the biotin-streptavidin ELISA results, all
three methods showed higher absorbance values for the same
ESAT-6 concentrations, especially the third method
(Figure 3), because more antibodies were able to bind GNP
and thus improved ESAT-6 detection; the streptavidin-HRPhe presence of NaCl. (a) Eighty nanometre GNPs were mixed with
nd photographs were taken 15 min after NaCl was added. GNP-
20 nm, and they retained the original red colour. GNPs only
rple colour.
ELISA. Two-hundred-fifty nanomolar ESAT-6 was detected by
th different combinations of GNP-conjugated GNPs. Method 3
Figure 5: Comparison of different sized GNPs. Ten and eight
nanometre GNPs were used to evaluate detection of ESAT-6.
Two-hundred-fifty nanomolar ESAT-6 was detected by both 10
and 80 nm sized GNP. Eighty nanometre GNP shows the best
results.
Signal enhancement in ELISA436conjugated GNP especially increased the binding of biotin
and streptavidin.
Limit of detection of ESAT-6
Because GNP-conjugated biomolecules improved the
detection of ESAT-6, we next titrated ESAT-6 from 8 to
250 nM to determine the limit of detection of ESAT-6 by all
three methods. As shown in Figure 4, all three methods
(including the biotin-streptavidin ELISA) were able to detect
as little as 8 nMESAT-6 (Figure 4). However, ELISAwithout
GNP was able to detect significantly lower (1 nM)
concentrations of ESAT-6 compared to assays using ESAT-6
antibody-GNP or ESAT-6 antibody-GNP and biotinylated
anti-mouse-IgG-GNP. The detection of ESAT-6 at 120 and
250 nM was the same due to saturation by ESAT-6. Interest-
ingly, streptavidin-GNP improved ESAT-6 detection for all
concentrations. SaturationofESAT-6beganat 60nMbecause
streptavidin-GNP-HRP has a greater chance of binding.
ESAT-6 detection improved using 80 nm GNP
For comparison, we used 80 -nm sized GNPs to
generate ESAT-6 antibody-GNP, anti-mouse-IgG-GNP,
biotin-anti-mouse IgG-GNP and streptavidin-HRP-GNP.
First, we checked whether 250 nM ESAT-6 was detected
best by 10 or 80 nm sized GNP (Figure 5). Because the
third method gave the best results previously, we used
this method to compare the GNP sizes. As shown in
Figure 5, 80 nm GNP increased the detection limits
compared to 10 nm GNP because more antibodies were
able to bind the 80 nm GNP. Because 80 nm GNP gaveFigure 4: Limit of detection of ESAT-6. ESAT-6 was titrated with
concentrations ranging from 0 to 500 nM. (a) Conventional
ELISA, (b) ELISA with ESAT-6 antibody-GNP, (c) ELISA with
ESAT-6 antibody-GNP and biotinylated anti-mouse-IgG-GNP,
(d) ELISA with ESAT-6 antibody-GNP, biotinylated anti-
mouse-IgG-GNP, and streptavidin-HRP-GNP. Ten nanometre
GNPs were used in all experiments. The figure inset shows the
colour change of the solution after adding the HRP substrate. As
the concentration of ESAT-6 increased, the colour intensity also
increased.the best results, we determined their detection limits for
ESAT-6 compared to conventional ELISA. The limits of
detection reached 1 nM in these experiments without
GNPs; however, GNPs increased the limits of detection for
all of the tested concentrations of ESAT-6 (Figure 6).
Compared with 10 nm GNP, 80 nm GNP increased the
limit of detection using the same concentration of ESAT-
6. Additionally, there was a significant increase in the
limit of detection for all of the concentrations of ESAT-6
using 80 nm GNP (Figure 6).Figure 6: Limit of detection determined by conventional ELISA
assisted by GNP based ELISA. ESAT-6 was titrated with the
concentrations ranging from 0.5 to 500 nM. Graphical represen-
tation of OD with the above experiments. Limit of detection for
both conventional and GNP-assisted ELISAs were similar, but the
use of GNPs increased the OD for all concentrations. Eighty
nanometre GNP was used in all experiments. The figure inset
shows the colour change of the solution after adding the HRP
substrate. As the concentration of ESAT-6 increased, he colour
intensity also increased.
T. Lakshmipriya et al. 437Discussion
ELISA is a precise detection system for a wide range of
targets when the correct antibody is used. Because ELISAs
can detect biomolecules in crude samples, such as serum,
improving binding affinities for different biomolecules to
reach maximum sensitivity can be helpful for detecting dis-
ease. Biotin-streptavidin is already widely used in many
biotechnology fields due to their strong interactions; it is
particularly useful in biosensor development to improve the
detection of the system. Moreover, nanoparticles, such as
GNP, have also been used in a similar way to improve
detection. In this study, we used this commonly used tech-
nology to improve the limit of detection of ELISA. More-
over, nanoparticles have also been used for a long time as
biosensors to improve the limit of detection. Among nano-
particles, GNP is a very popular particle in sensor develop-
ment. ELISA combined with GNP displays improved
biomolecular detection. Han et al.18 used a GNP-conjugated
detection antibody and DNA for the detection of protein;
these conjugations were successfully used to simultaneously
detect two different biomarkers in human serum.
The biotin-streptavidin interaction was expected to
improve the limit of detection of ESAT-6 because biotin and
streptavidin have a strong binding affinity with a femtomolar
dissociation constant.19 If only a small amount of
biotinylated anti-mouse-IgG binds to the ESAT-6 anti-
body, streptavidin has a greater chance of binding ESAT-6
because streptavidin has four biotin-binding sites. Thus,
ESAT-6 should be detected at even lower concentrations.
Among the three methods tested, method three worked best
because more antibodies were able to bind GNP and
improved ESAT-6 detection, especially streptavidin-HRP
conjugated GNP, which increased the binding affinity be-
tween biotin and streptavidin. Regarding sensitivity, all three
methods were able to detect as little as 8 nM of ESAT-6,
including biotin-streptavidin ELISA because the strong
biotin-streptavidin interaction improves the sensitivity of the
assay. Because 10-nm sized GNP in the above assay
improved the optical density of the detection of ESAT-6, the
same experiment was carried out with 80 nm GNP because
we thought that more antibodies could bind 80 nm GNP. As
expected there was an increased ability to detect ESAT-6
with 80 nm GNP.
The experiments described herein showed that there is no
change of the limit of detection without GNP due to the
saturated binding of biotin and streptavidin. Simultaneously,
the visible detection of ELISA was greatly improved when
biomolecules were immobilized on the GNP surface. GNPs
have often been used in sensor development to enhance the
detection of a given compound. For example, a mixture of an
antibody with GNP or an aptamer with GNP was found to
improve the limit of detection to the lower femtomolar range
using a surface Plasmon-based Biacore system.9,11
Lakshmipriya et al.11 found that GNP-conjugated anti-
mouse-IgG improved the limit of detection of Factor IX
protein to the low picomolar range in a SPR-based Biacore
system. Gopinath et al.20 reported that antibody-conjugated
GNP improved influenza detection in the waveguide mode
sensor. GNPs are also commonly used in the Raman-
scattering system to detect biomolecules and in commercialdetection kits (e.g., immunochromatography pregnancy
test). In the present study, our GNP-assisted ELISA suc-
cessfully detected ESAT-6 with a high performance typical of
that of other demonstrated GNP-based assays. This strategy
can be similarly used for other important targets.21e27
Conclusions
ESAT-6 is an early secreted protein by M. tuberculosis;
here, we detected ESAT-6 by both conventional ELISA and
GNP-assisted ELISA with appropriate antibodies.
Compared with biotin-streptavidin based ELISA, GNP
based ELISA improved the optical density for all concen-
trations of ESAT-6, but the limit of detection was found to be
the same using both methods. Use of 80 nmGNP-conjugated
biomolecules improved the detection of ESAT-6 compared
with 10 nm. Thus, GNP-based ELISA was able to detect
ESAT-6 at lower concentrations (1 nM) and is suitable for
diagnosing the early stage of infection. Moreover, this strat-
egy should be applicable to the early detection of other dis-
eases, such as influenza andHuman Immunodeficiency Virus.
Conflict of interest
The authors have no conflict of interest to declare.
Authors’ contributions
TL performed the experiments, analysed the data, wrote
the manuscript; SCBG designed the experiments, analysed
the data, wrote the manuscript; UH supervised the work;
THT supervised the work and provided the materials; and all
of the authors read and approved the final version of the
manuscript.
Acknowledgements
T. Lakshmipriya was supported by a post-doctoral
research fellowship from Universiti Sains Malaysia.
References1. Dixit CK, Vashist SK, O’neill FT, O’reilly B, MacCraith BD,
O’kennedy R. Development of a high sensitivity rapid sandwich
ELISA procedure and its comparison with the conventional
approach. Anal Chem 2010; 82: 7049–7052. http://dx.doi.org/
10.1021/ac101339q.
2. Dixit CK, Vashist SK, MacCraith BD, O’Kennedy R. Multi-
substrate-compatible ELISA procedures for rapid and high-
sensitivity immunoassays. Nat Protoc 2011; 6: 439–445. http://
dx.doi.org/10.1038/nprot.2011.304.
3. Shams H, Weis SE, Klucar P, Lalvani A, Moonan PK,
Pogoda JM, et al. Enzyme-linked immunospot and tuberculin
skin testing to detect latent tuberculosis infection. Am J Respir
Crit Care Med 2005; 172: 1161–1168. http://dx.doi.org/10.1164/
rccm.200505-748OC.
4. Liu QL, Yan XH, Yin Xm, Situ B, Zhou HK, Lin L, et al.
Electrochemical enzyme-linked immunosorbent assay (ELISA)
for a-fetoprotein based on glucose detection with multienzyme-
nanoparticle amplification. Molecules 2013; 18: 12675–12686.
http://dx.doi.org/10.3390/molecules181012675.
Signal enhancement in ELISA4385. Li X, Li G, Teng Q, Yu L, Wu X, Li Z. Development of a
blocking ELISA for detection of serum neutralizing antibodies
against newly emerged duck Tembusu virus. PLoS One 2012; 7:
e53026. http://dx.doi.org/10.1371/journal.pone.0053026.
6. Guimaraes AJ, Pizzini CV, De Matos Guedes HL,
Albuquerque PC, Peralta JM, Hamilton AJ, et al. ELISA for
early diagnosis of histoplasmosis. J Med Microbiol 2004; 53:
509–514. http://dx.doi.org/10.1099/jmm.0.05469-0.
7. Vashist SK. A sub-picogram sensitive rapid chemiluminescent
immunoassay for the detection of human fetuin A. Biosens
Bioelectron 2013; 40: 297–302. http://dx.doi.org/10.1016/
j.bios.2012.07.067.
8. Perumal V, Hashim U, Gopinath SCB, Haarindraprasad R,
Foo KL, Balakrishnan SR, et al. “Spotted Nanoflowers”: gold-
seeded zinc oxide nanohybrid for selective bio-capture. Sci Rep
2015; 5: 12231. http://dx.doi.org/10.1038/srep12231.
9. Kim S, Lee J, Lee SJ, Lee HJ. Ultra-sensitive detection of IgE
using biofunctionalized nanoparticle-enhanced SPR. Talanta
2010; 81: 1755–1759. http://dx.doi.org/10.1016/j.talanta.2010.
03.036.
10. Gopinath SCB, Awazu K, Fujimaki M, Shimizu K, Shima T.
Observations of immuno-gold conjugates on influenza viruses
using waveguide-mode sensors. PLoS One 2013; 8: 1–10. http://
dx.doi.org/10.1371/journal.pone.0069121.
11. Lakshmipriya T, Horiguchi Y, Nagasaki Y. Co-immobilized
poly(ethylene glycol)-block-polyamines promote sensitivity and
restrict biofouling on gold sensor surface for detecting factor IX
in human plasma. Analyst 2014; 139: 3977–3985. http://
dx.doi.org/10.1039/c4an00168k.
12. Lakshmipriya T, Fujimaki M, Gopinath SCB, Awazu K,
Horiguchi Y, Nagasaki Y. A high-performance waveguide-
mode biosensor for detection of factor IX using PEG-based
blocking agents to suppress non-specific binding and improve
sensitivity. Analyst 2013; 138: 2863–2870. http://dx.doi.org/
10.1039/c3an00298e.
13. Brites D, Gagneux S. Co-evolution of Mycobacterium tubercu-
losis and Homo sapiens. Immunol Rev 2015; 264: 6–24. http://
dx.doi.org/10.1111/imr.12264.
14. Geluk A, van Meijgaarden KE, Franken KLMC,
Subronto YW, Wieles B, Arend SM, et al. Identification and
characterization of the ESAT-6 homologue of Mycobacterium
leprae and T-cell cross-reactivity with Mycobacterium tubercu-
losis. Infect Immun 2002; 70: 2544–2548. http://dx.doi.org/
10.1128/IAI.70.5.2544.
15. Dorman SE. New diagnostic tests for tuberculosis: bench,
bedside, and beyond. Clin Infect Dis 2010; 50(Suppl 3):
S173–S177. http://dx.doi.org/10.1086/651488.
16. Bothamley GH. Serological diagnosis of tuberculosis. Eur
Respir J 1995;(Suppl 20): 676s–688s.
17. Brock I, Munk ME, Kok-Jensen A, Andersen P. Performance
of whole blood IFN-gamma test for tuberculosis diagnosis
based on PPD or the specific antigens ESAT-6 and CFP-10. IntJ Tuberc Lung Dis 2001; 5: 462–467. Available: http://www.
ncbi.nlm.nih.gov/pubmed/11336278.
18. Han KC, Yang EG, Ahn DR. A highly sensitive, multiplex
immunoassay using gold nanoparticle-enhanced signal amplifi-
cation. Chem Commun 2012; 48: 5895. http://dx.doi.org/
10.1039/c2cc31659e.
19. Green NM. Advances in protein chemistry. Adv Protein Chem
1975; 29. http://dx.doi.org/10.1016/S0065-3233(08)60411–8.
20. Gopinath SCB, Awazu K, Fujimaki M, Shimizu K. Evaluation
of anti-A/Udorn/307/1972 antibody specificity to influenza A/
H3N2 viruses using an evanescent-field coupled waveguide-
mode sensor. PLoS One 2013; 8: e81396. http://dx.doi.org/
10.1371/journal.pone.0081396.
21. Balakrishnan SR, Hashim U, Gopinath SCB, Poopalan P,
RamayyaHR,VeeradasanP, et al. Polysiliconnanogap lab-on-chip
facilitatesmultiplex analyseswith single analyte.BiosensBioelectron
2015. http://dx.doi.org/10.1016/j.bios.2015.10.075. Elsevier.
22. Gopinath SCB, Hayashi K, Kumar PKR. Aptamer that binds
to the gD Protein of Herpes Simplex Virus 1 and efficiently
inhibits viral entry. J Virol 2012; 86: 6732–6744. http://
dx.doi.org/10.1128/JVI.00377-12.
23. Gopinath SCB, Shikamoto Y, Mizuno H, Kumar PKR. Snake-
venom-derived factor IX-binding protein specifically blocks the
gamma-carboxyglutamic acid-rich-domain-mediated mem-
brane binding of human factors IX and X. Biochem J 2007; 405:
351–357. http://dx.doi.org/10.1042/BJ20061737.
24. Anbu P, Gopinath SCB, Hilda A, Mathivanan N,
Annadurai G. Secretion of keratinolytic enzymes and kerati-
nolysis by Scopulariopsis brevicaulis and Trichophyton menta-
grophytes: regression analysis. Can J Microbiol 2006; 52: 1060–
1069. http://dx.doi.org/10.1139/w06-067.
25. Gopinath SCB, Balasundaresan D, Akitomi J, Mizuno H. An
RNA aptamer that discriminates bovine factor IX from human
factor IX. J Biochem 2006; 140: 667–676. http://dx.doi.org/
10.1093/jb/mvj203.
26. Kumarevel T, Gopinath SCB, Nishikawa S, Mizuno H,
Kumar PKR. Identification of important chemical groups of the
hut mRNA for HutP interactions that regulates the hut operon
inBacillus subtilis.Nucleic Acids Res 2004; 32: 3904–3912. http://
dx.doi.org/10.1093/nar/gkh725.
27. Kumarevel T, Tanaka T, Nishio M, Gopinath SCB, Takio K,
Shinkai A, et al. Crystal structure of the MarR family regula-
tory protein, ST1710, from Sulfolobus tokodaii strain 7.
J Struct Biol 2008; 161: 9–17. http://dx.doi.org/10.1016/
j.jsb.2007.08.017.How to cite this article: Lakshmipriya T, Gopinath SCB,
Hashim U, Tang T-H. Signal enhancement in ELISA:
Biotin-streptavidin technologyagainst gold nanoparticles.
J Taibah Univ Med Sc 2016;11(5):432e438.
